• HOME
    KOREAN
    CHINESS
    SITE MAP
    JOIN
  • Username (Site Login ID)
  • Password
  • Forgot your password?

  • °ÔÀÓ¼³°è | Cases and Studies of Game Design in Lottery & Gambling | êý戏设计

    date : 2015-05-20 01:10|hit : 3970
    Article] A Decrement in Probabilistic Category Learning in Cocaine Users After Controlling for Marijuana and Alcohol Use
    DocNo of ILP: 164

    Doc. Type: Article

    Title: A Decrement in Probabilistic Category Learning in Cocaine Users After Controlling for Marijuana and Alcohol Use

    Authors: Vadhan, NP; Myers, CE; Benedict, E; Rubin, E; Foltin, RW; Gluck, MA

    Full Name of Authors: Vadhan, Nehal P.; Myers, Catherine E.; Benedict, Elysia; Rubin, Eric; Foltin, Richard W.; Gluck, Mark A.

    Keywords by Author: cocaine; stimulus-response learning; habit learning; striatum; neuropsychological; cognitive

    Keywords Plus: DECISION-MAKING; BASAL GANGLIA; NEUROCOGNITIVE DEFICITS; BEHAVIORAL TREATMENT; PARKINSONS-DISEASE; SUBSTANCE-ABUSE; DRUG-ADDICTION; GAMBLING TASK; DEPENDENCE; IMPAIRMENT

    Abstract: Aspects of stimulus-response (S-R) learning, mediated by striatal dopamine signaling, have been found to be altered in cocaine users relative to healthy controls. However, the influence of cocaine users' marijuana and alcohol use has not been accounted for. This study evaluated S-R learning and other neurocognitive functions in cocaine users while controlling for the relative influences of marijuana and alcohol use. Twenty-five long-term cocaine users and 2 control groups (25 moderate marijuana and alcohol users and 23 healthy controls) completed a computerized assessment of probabilistic category learning (the Weather Prediction task), as well as measures of equivalence learning, declarative learning, and executive, attentional, and motor function. Cocaine users exhibited decreased performance on the Weather Prediction task, as well as measures of declarative learning, attention, and motor function (p < 0.05), relative to both control groups. Cocaine users exhibited decrements in probabilistic category learning, declarative recall, and attentional and motor function, compared with both marijuana and alcohol users and nondrug users. Therefore, these decrements appear to be specifically related to the cocaine use, but not the moderate marijuana and alcohol use, of long-term cocaine users.

    Cate of OECD: Psychology

    Year of Publication: 2014

    Business Area: gamble

    Detail Business: gamble

    Country: USA

    Study Area:

    Name of Journal: EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY

    Language: English

    Country of Authors: [Vadhan, Nehal P.; Rubin, Eric; Foltin, Richard W.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY USA; [Vadhan, Nehal P.; Rubin, Eric; Foltin, Richard W.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Myers, Catherine E.] VA New Jersey Hlth Care Syst, Res Serv, E Orange, NJ USA; [Myers, Catherine E.] Rutgers Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ USA; [Benedict, Elysia] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York State Psychiat Inst, New York, NY USA; [Benedict, Elysia] Long Isl Univ, Dept Psychol, Greenvale, NY USA; [Gluck, Mark A.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Piscataway, NJ 08855 USA

    Press Adress: Vadhan, NP (reprint author), NY State Psychiat Inst, 1051 Riverside Dr 120, New York, NY 10032 USA.

    Email Address: npv2101@columbia.edu

    Citaion:

    Funding: NIDA [09236, 008105, 019933]; Columbia University's CTSA from NCATS-NCRR/NIH [UL1 RR024156]; Columbia University Irving Scholars Award

    Lists of Citation: Aharonovich E, 2003, DRUG ALCOHOL DEPEN, V71, P207, DOI 10.1016/S0376-8716(03)00092-9; Bates ME, 2002, EXP CLIN PSYCHOPHARM, V10, P193, DOI 10.1037//1064-1297.10.3.193; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Bedi G, 2008, PSYCHOL MED, V38, P1319, DOI 10.1017/S0033291708002730; Bohnen NI, 2007, NEUROSCI LETT, V424, P185, DOI 10.1016/j.neulet.2007.07.035; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Carpenter KM, 2012, AM J DRUG ALCOHOL AB, V38, P146, DOI 10.3109/00952990.2011.643986; Di Chiara G, 1999, EUR J PHARMACOL, V375, P13, DOI 10.1016/S0014-2999(99)00372-6; Ersche KD, 2013, MOL PSYCHIATR, V18, P134, DOI 10.1038/mp.2012.31; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; EYSENCK SBG, 1978, PSYCHOL REP, V43, P1247; First M. B, 1995, STRUCTURED CLIN INTE; Garavan H, 2005, TRENDS COGN SCI, V9, P195, DOI 10.1016/j.tics.2005.02.008; Gillen RW, 1998, PROG NEURO-PSYCHOPH, V22, P1061, DOI 10.1016/S0278-5846(98)00057-8; Gluck MA, 2002, LEARN MEMORY, V9, P408, DOI 10.1101/lm.45202; Golden CJ, 1978, STROOP COLOR WORD TE; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039830; Gonzalez R, 2008, NEUROPSYCHOLOGY, V22, P776, DOI 10.1037/a0013404; Heaton RK, 1991, COMPREHENSIVE NORMS; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; Kalapatapu RK, 2011, AM J ADDICTION, V20, P228, DOI 10.1111/j.1521-0391.2011.00128.x; Knowlton B J, 1994, Learn Mem, V1, P106; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Lie CH, 2006, NEUROIMAGE, V30, P1038, DOI 10.1016/j.neuroimage.200510031; Marsh R, 2004, ARCH GEN PSYCHIAT, V61, P1259, DOI 10.1001/archpsyc.61.12.1259; Martinez D, 2007, AM J PSYCHIAT, V164, P622, DOI 10.1176/appi.ajp.164.4.622; Martinez D, 2011, AM J PSYCHIAT, V168, P634, DOI 10.1176/appi.ajp.2010.10050748; Martinez D, 2004, NEUROPSYCHOPHARMACOL, V29, P1190, DOI 10.1038/sj.npp.1300420; Moustafa AA, 2010, BRAIN COGNITION, V74, P132, DOI 10.1016/j.bandc.2010.07.013; Myers CE, 2003, J COGNITIVE NEUROSCI, V15, P185, DOI 10.1162/089892903321208123; Myers CE, 2008, NEUROPSYCHOLOGY, V22, P681, DOI 10.1037/0894-4105.22.5.681; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037//0894-4105.13.4.564; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Reitan R. M., 1985, HALSTEAD REITAN NEUR; Robinson JE, 1999, J INT NEUROPSYCH SOC, V5, P10; Shohamy D, 2004, BEHAV NEUROSCI, V118, P676, DOI 10.1037/0735-7044.118.4.676; Smelson DA, 1999, AM J DRUG ALCOHOL AB, V25, P377, DOI 10.1081/ADA-100101867; Solowij Nadia, 2008, Curr Drug Abuse Rev, V1, P81; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Toomey R, 2003, ARCH GEN PSYCHIAT, V60, P303, DOI 10.1001/archpsyc.60.3.303; Tuchman E, 2010, J ADDICT DIS, V29, P127, DOI 10.1080/10550881003684582; Vadhan NP, 2008, DRUG ALCOHOL DEPEN, V93, P155, DOI 10.1016/j.drugalcdep.2007.09.013; Vadhan NP, 2009, DRUG ALCOHOL DEPEN, V102, P95, DOI 10.1016/j.drugalcdep.2009.02.003; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V90, P2, DOI 10.1016/j.drugalcdep.2007.02.004; Wang GJ, 1997, LIFE SCI, V61, P1059, DOI 10.1016/S0024-3205(97)00614-0; Weber E, 2012, DRUG ALCOHOL DEPEN, V125, P146, DOI 10.1016/j.drugalcdep.2012.04.002; Woicik PA, 2009, NEUROPSYCHOPHARMACOL, V34, P1112, DOI 10.1038/npp.2008.60

    Number of Citaion: 50

    Publication: AMER PSYCHOLOGICAL ASSOC

    City of Publication: WASHINGTON

    Address of Publication: 750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA

    ISSN: 1064-1297

    29-Character Source Abbreviation: EXP CLIN PSYCHOPHARM

    ISO Source Abbreviation: Exp. Clin. Psychopharmacol.

    Volume: 22

    Version: 1

    Start of File: 65

    End of File: 74

    DOI: 10.1037/a0034506

    Number of Pages: 10

    Web of Science Category: Psychology, Biological; Psychology, Clinical; Pharmacology & Pharmacy; Psychiatry

    Subject Category: Psychology; Pharmacology & Pharmacy; Psychiatry

    Document Delivery Number: AA7HV

    Unique Article Identifier: WOS:000331269200008

    [ÀÌ °Ô½Ã¹°Àº HyeJung Mo¡¦´Ô¿¡ ÀÇÇØ 2015-05-20 14:56:52 GAMBLING¿¡¼­ À̵¿ µÊ]
    reply : 0
  • list
  • prev
  • next